ConductScience.org, home

Paper18199029

Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.

Chang JY and 6 others. J Infect Dis, 2008. Cited by 793 papers, by iCite.

Cite this record

ConductScience Library. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. Papers, record 18199029. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18199029

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.
PubMed
Journal
J Infect Dis
PubMed
Year
2008
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
793
iCite
Relative citation ratio, by iCite
21
iCite
Revised in PubMed
2022-04-19
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chang JYJu Young
2Antonopoulos DADionysios A
3Kalra AApoorv
4Tonelli AAdriano
5Khalife WTWalid T
6Schmidt TMThomas M
7Young VBVincent B

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Clostridioides difficileMajor topic
Enterocolitis, PseudomembranousMajor topic
FecesMajor topic
Diarrhea
Drug Administration Schedule
Female
Genetic Variation
Humans
Male
Phylogeny
Recurrence
Reference Values

Source PubMed

Download CSV of topics

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT02255305FMT Versus Antimicrobials for Initial Treatment of Recurrent CDIBackgroundClinicalTrials.gov
NCT02449174Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral RouteBackgroundClinicalTrials.gov
NCT05770726Probiotics Administration Via Colonoscopic Spray and Oral Administration in CDAD PatientsResultsClinicalTrials.gov

Download CSV of trials

Cited by540

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 793 citations.

PMIDTitleJournalYearIn PapersSource
42881491The Trajectory of Gastrointestinal Symptom Experience Following Fecal Microbiota Transplant for Recurrent Clostridioides Difficile Infection.J Clin Gastroenterol2026https://conductscience.org/library/papers/42881491PubMed
42752228Cross-feeding enables robust coexistence between four bacterial species.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/42752228PubMed
42746219Microbiota-mitochondria axis in neurodegenerative disorders and retinal dysfunction: mechanisms and emerging therapeutic opportunities.Front Pharmacol2026https://conductscience.org/library/papers/42746219PubMed
42712936Antibiotic-induced gut microbiota dysbiosis and bile acid metabolism: implications for intestinal health, immune regulation, and disease susceptibility.Front Microbiol2026https://conductscience.org/library/papers/42712936PubMed
42689867Gut microbiota and metabolic alterations in participants with flatulence identify Faecalibacterium prausnitzii as a key microbial target for clinical intervention.Gut Microbes2026https://conductscience.org/library/papers/42689867PubMed
42379287The impact of fecal microbiota transplantation on host immunity and epithelial restoration following Clostridioides difficile infection.Anaerobe2026https://conductscience.org/library/papers/42379287PubMed
42228606Microbial shifts in early life: the pediatric gut microbiome and its role in health and disease.Gut Microbes2026https://conductscience.org/library/papers/42228606PubMed
42184295The human microbiome at translational crossroads: an ecological and causal perspective.Singapore Med J2026https://conductscience.org/library/papers/42184295PubMed
41853554Live biotherapeutic products: a capstone for prevention of recurrent Clostridiodes difficile infection.Front Microbiomes2024https://conductscience.org/library/papers/41853554PubMed
41853542Characterization of double humanized BLT-mice with stable engraftment of a human gut bacterial microbiome.Front Microbiomes2024https://conductscience.org/library/papers/41853542PubMed
41853341Chicken caecal enterotypes in indigenous Kadaknath and commercial Cobb chicken lines are associated with Campylobacter abundance and influenced by farming practices.Front Microbiomes2023https://conductscience.org/library/papers/41853341PubMed
41798990Microbiota management: a perspective for kidney transplant patients.Front Transplant2026https://conductscience.org/library/papers/41798990PubMed
41675702Clostridium difficile and gut health: Bacteria, the gut microbiome, and diet.IMetaOmics2025https://conductscience.org/library/papers/41675702PubMed
41612266Intestinal fungal dysbiosis in gestational diabetes mellitus is associated with adverse pregnancy outcomes.BMC Pregnancy Childbirth2026https://conductscience.org/library/papers/41612266PubMed
41601894A novel functional water significantly modulates the gut microbiota and decreases the basal level of inflammation in mice.Front Nutr2025https://conductscience.org/library/papers/41601894PubMed
41601294Sex-Dependent Microbial and Host Profiles Following Fecal Microbiota and Bifidobacterium longum Treatment in Stress-Induced Gut Dysbiosis.Gut Liver2026https://conductscience.org/library/papers/41601294PubMed
41526647Longitudinal multiomics analysis of endocrine therapy effects and gut microbiota in breast cancer recurrence.Commun Med (Lond)2026https://conductscience.org/library/papers/41526647PubMed
41230019Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA®) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial.Ther Adv Gastroenterol2025https://conductscience.org/library/papers/41230019PubMed
41077748Predictors of Treatment Response to Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Pilot Study.J Neurogastroenterol Motil2025https://conductscience.org/library/papers/41077748PubMed
41042595Unravelling three-way interactions between Clostridioides difficile, microbiota and the host.J Med Microbiol2025https://conductscience.org/library/papers/41042595PubMed

See all 540 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18199029

GET https://conductscience.org/api/papers/v1/18199029/cited_by?page=2